RAPT Therapeutics, Inc.

Q2 2023 13F Holders

Symbol: RAPT
CUSIP: 75382E109
Type: Equity
Class: COM
Num filings: 102
Total reported value, excl. options: $637 M

Compare 2023 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type